Literature DB >> 6492289

Mineralocorticoid excess secondary to adrenal cortical carcinoma.

N N Stone, A Janoski, W Muakkassa, L Shpritz.   

Abstract

Adrenal cortical carcinoma may present solely with a syndrome of mineralocorticoid excess. Primary aldosteronism, resulting from adrenal carcinoma, is unusual and has only been reported rarely. A review of the literature revealed 19 cases with marked hypertension and hypokalemia, resulting from mineralocorticoid excess produced by adrenal cortical carcinoma. We report an additional case that supports the hypothesis that adrenal carcinoma may mimic hyperaldosteronism. Extensive assay of adrenal function will demonstrate the presence of biologically inactive steroids, suggesting the presence of adrenal cortical carcinoma.

Entities:  

Mesh:

Year:  1984        PMID: 6492289     DOI: 10.1016/s0022-5347(17)49969-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Circadian rhythm as a therapeutic target.

Authors:  Wei Ruan; Xiaoyi Yuan; Holger K Eltzschig
Journal:  Nat Rev Drug Discov       Date:  2021-02-15       Impact factor: 84.694

2.  Primary hyperaldosteronism caused by adrenocortical carcinoma.

Authors:  H W Scott; C R Sussman; D L Page; N W Thompson; M D Gross; R Lloyd
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 3.  Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications.

Authors:  Monika Haack; Norah Simpson; Navil Sethna; Satvinder Kaur; Janet Mullington
Journal:  Neuropsychopharmacology       Date:  2019-06-17       Impact factor: 7.853

Review 4.  Sleep and neurological autoimmune diseases.

Authors:  Alex Iranzo
Journal:  Neuropsychopharmacology       Date:  2019-07-14       Impact factor: 7.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.